tiprankstipranks
Trending News
More News >
Alphamab Oncology (HK:9966)
:9966
Hong Kong Market

Alphamab Oncology (9966) Similar Stocks

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Alphamab Oncology
HK$7.35
HK$7.04B
39.18
162.50%
Ascletis Pharma, Inc.
HK$9.69
HK$8.90B
829.17%
0 Buy
0 Hold
0 Sell
Hold
HBM Holdings Ltd.
HK$7.76
HK$6.87B
268.62
494.66%
Lepu Biopharma Co. Ltd. Class H
HK$5.40
HK$9.24B
31.68%
Abbisko Cayman Limited
HK$10.24
HK$6.77B
174.45
227.16%
0 Buy
0 Hold
0 Sell
Moderate Buy
SinoMab Bioscience Ltd.
HK$2.07
HK$2.47B
24.12%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:9966
Alphamab Oncology
6.93
4.29
162.50%
HK:1672
Ascletis Pharma, Inc.
8.92
8.01
880.22%
HK:2142
HBM Holdings Ltd.
7.79
6.48
494.66%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.32
1.28
31.68%
HK:2256
Abbisko Cayman Limited
10.24
7.10
226.11%
HK:3681
SinoMab Bioscience Ltd.
2.11
0.44
26.35%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis